Shares of Arena Pharmaceuticals Inc. (NASDAQ: ARNA) saw an incredible gain early Tuesday after ... Excluding Tuesday’s move, Arena had outperformed the broad markets, with the stock up nearly 30% year to date. However, over …
voluntarily delisting of Mylan's ordinary shares from the Tel Aviv Stock Exchange and Vanda's disappointment over Fanaptum's failure to win the CHMP's backing. Arena Pharmaceuticals Inc.'s (ARNA) phase II study of Etrasimod in …
Arena Pharmaceuticals, Inc. ARNA is scheduled to report third-quarter 2016 results on Nov 7, after the market closes. The company met earnings expectations last quarter. Over the four trailing quarters, it has recorded an average positive …
Arena Pharmaceuticals (NASDAQ ... leads the analysts to believe they will approve ARNA's lorcaserin. ARNA traded as high as $5.70 before the Panel announcement, only to crash to $3.60 2 hours later. The stock rebounded to $4.50 in …
For a hedged play on Arena Pharmaceuticals (ARNA) MarketIntelligenceCenter.com’s patented trade-picking algorithms selected a Jul 20, 2018 $35 covered call for a net debit in the $30.23 area. That is also the break-even stock price for …
Most biotech stocks have recovered, at least to some extent, during the overall stock market’s most recent run to new highs. However, some haven’t. Wall Street has been betting heavily against Arena Pharmaceuticals (NASDAQ: …
Arena Pharmaceuticals (NASDAQ:ARNA) imploded 16% on worries over its obesity drug ... BURL), whose Coat Factory was located near New York's Ground Zero, rose 47.12% in its stock market debut last week. Today in economics, …
Arena Pharmaceuticals, Inc. (ARNA) was a big mover last session, as the company saw its shares rise by over 17% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARNA at https://www.zacks.com/ap/ARNA
Arena Pharmaceuticals, Inc. ARNA is a biopharmaceutical company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings …